Latest rheumatoid arthritis Stories
Based on 14-3-3eta protein biomarker for aiding early RA diagnosis through an exclusive license with Augurex Life Sciences MADISON, N.J., April 9, 2013 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced the availability of two new blood tests for aiding the early diagnosis of rheumatoid arthritis (RA), an autoimmune disorder that can cause debilitating joint damage. The lab-developed tests are based on the...
SOUTH SAN FRANCISCO, Calif., April 5, 2013 /PRNewswire/ -- AstraZeneca today announced top-line results of OSKIRA-1, a Phase 3 study to assess the efficacy and safety of fostamatinib, the first oral spleen tyrosine kinase (SYK) inhibitor in development for rheumatoid arthritis (RA). OSKIRA-1 had two primary endpoints: assessing signs and symptoms of RA as measured by ACR20 response rates, and an X-ray endpoint known as mTSS (modified Total Sharp Score). In the OSKIRA-1 study,...
Hormonal changes could precede development of the condition, say authors Low testosterone levels may herald the subsequent development of rheumatoid arthritis in men, suggests research published online in the Annals of the Rheumatic Diseases. Sex hormones are thought to play a part in the development of rheumatoid arthritis, and both men and women with the condition tend to have lower levels of testosterone in their blood than healthy people. But it is not clear whether this is a...
Three new studies review use, comparative effectiveness and cost SAN DIEGO, April 4, 2013 /PRNewswire/ -- In recent years, biologic anti-inflammatory (BAI) specialty medications used to treat autoimmune inflammatory conditions such as rheumatoid arthritis (RA), psoriasis and Crohn's disease, have seen double-digit percentage price increases. The potential exists to treat many more patients than are currently receiving a BAI medication, according to new studies presented today by...
Neurological Wellness Center physicians call on Floridians in the Fort Lauderdale area to participate in a clinical trial utilizing perispinally administered etanercept as an Alzheimer's disease treatment. (PRWEB) April 03, 2013 To enroll in this no cost clinical trial please visit blog.lef.org/2012/01/arthritis-drug-for-alzheimers-patients.html or call: 866-517-4536 between 9AM and 5PM ET. Neurological Wellness Center physicians have been treating Alzheimer's disease with low...
BOCA RATON, Fla., April 3, 2013 /PRNewswire/ -- A panel of experts in health care and business today highlighted the impact of rheumatoid arthritis and other chronic conditions on employers and women in the workplace. Rheumatoid Arthritis (RA) attacks women at a rate three times more than men, and comes at a cost that goes way beyond physical pain. With women making up about 50 percent of the U.S. workforce, the impact of rheumatoid arthritis on workplace productivity exceeds 47...
Neurological Wellness Center physician Rolando Rodriguez M.D. responds: "We have some of the answers now, enabling substantial recovery, the problem is delivering this treatment to the five million Americans suffering from Alzheimer's disease." (PRWEB) April 01, 2013 In his State of the Union address President Obama called for prioritizing medical research to "unlock the answers to Alzheimer's". Michelle Bachmann, in a letter posted on her website calls for...
HAYWARD, Calif., March 27, 2013 /PRNewswire/ -- Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), a biopharmaceutical company developing drugs to treat serious diseases associated with inflammation and autoimmune disorders, today announced it has initiated the CHABLIS-SC1 Phase 3 study of blisibimod, a novel inhibitor of B-Cell Activating Factor (BAFF) for the treatment of systemic lupus erythematosus (lupus). Lupus is a chronic autoimmune disease, which often leads to severe skin rash,...
HARRISBURG, Pa., March 26, 2013 /PRNewswire/ -- Annual medical costs are lower by $3,964 for individuals with rheumatoid arthritis and $2,430 for pregnant women when treated for gum disease, according to a fourth round of findings from an oral health study by United Concordia and Highmark Inc. "The latest findings from our landmark study continue to clearly demonstrate the importance of good oral health," said James Bramson, D.D.S., chief dental officer for United Concordia. "Plenty...
NORWALK, Conn., March 25, 2013 /PRNewswire/ -- UBM Medica US announces that Musculoskeletal Network highlights growing evidence supporting the idea that many conditions related to arthritis are caused by cross-reactions between immune responses against infections and damage to the body's own tissues. Diseases such as rheumatoid arthritis and lupus may be an indication of a defect in the body's ability to fight infection, rather than an over-reaction to it, writes rheumatologist...
